Your browser doesn't support javascript.
loading
Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC).
Mar, Nataliya; Dwabe, Sami; Baranda, Marlon N; Zarrabi, Kevin K; Eturi, Aditya; Gulati, Shuchi; Parikh, Mamta; Seyedin, Steven N; Kalebasty, Arash Rezazadeh.
Afiliación
  • Mar N; Division of Hematology/Oncology, University of California Irvine, Orange, CA. Electronic address: marn@hs.uci.edu.
  • Dwabe S; Division of Hematology/Oncology, University of California Irvine, Orange, CA.
  • Baranda MN; Norton Cancer Institute, Louisville, KY.
  • Zarrabi KK; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA.
  • Eturi A; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA.
  • Gulati S; Division of Hematology/Oncology, University of California Davis, Sacramento, CA.
  • Parikh M; Division of Hematology/Oncology, University of California Davis, Sacramento, CA.
  • Seyedin SN; Department of Radiation Oncology, University of California Irvine, Orange, CA.
  • Kalebasty AR; Division of Hematology/Oncology, University of California Irvine, Orange, CA.
Clin Genitourin Cancer ; 22(2): 217-223, 2024 04.
Article en En | MEDLINE | ID: mdl-38087703

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antígeno Prostático Específico / Neoplasias de la Próstata Resistentes a la Castración Límite: Humans / Male Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antígeno Prostático Específico / Neoplasias de la Próstata Resistentes a la Castración Límite: Humans / Male Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2024 Tipo del documento: Article